Protagenic Therapeutics, Inc.\new Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.67M, a 45.8% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the twelve months ending June 30, 2024 was -$6.05M, a 74.7% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2023 was -$4.53M, a 27.2% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2022 was -$3.56M, a 14.1% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2021 was -$4.14M, a 62.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.53M -$969K -27.2% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 -$3.56M +$583K +14.1% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$4.14M -$1.59M -62.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$2.55M -$465K -22.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-07
2019 -$2.09M +$228K +9.85% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$2.31M +$51.2K +2.16% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-29
2017 -$2.37M -$132K -5.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$2.23M -$1.21M -118% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$1.03M -$733K -251% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-05-08
2014 -$292K Jan 1, 2014 Dec 31, 2014 8-K/A 2016-07-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.